These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20044465)

  • 1. Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
    Orfanos SE; Langleben D
    Eur Respir J; 2010 Jan; 35(1):223-4. PubMed ID: 20044465
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension.
    Dorfmüller P; Montani D; Humbert M
    Eur Respir J; 2010 Jan; 35(1):6-8. PubMed ID: 20044455
    [No Abstract]   [Full Text] [Related]  

  • 4. The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.
    Mukerjee D; Yap LB; Ong V; Denton CP; Howells K; Black CM; Coghlan JG
    Ann Rheum Dis; 2004 Dec; 63(12):1627-31. PubMed ID: 15547087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension as symptom of a limited form of systemic sclerosis in a nonagenerian].
    Fernández Ibáñez JM; Morales Ballesteros C; Carrasco Fernández JA; Perez Alonso L
    Rev Esp Geriatr Gerontol; 2010; 45(6):361-2. PubMed ID: 20678826
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
    Distler O; Behrens F; Huscher D; Foeldvari I; Zink A; Nash P; Denton CP; Humbert M; Matucci-Cerinic M; Seibold J; Rubin L; Furst DE
    Rheumatology (Oxford); 2006 Dec; 45(12):1455-7. PubMed ID: 16920751
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 9. Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
    Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND
    Eur J Intern Med; 2012 Dec; 23(8):e210-1. PubMed ID: 23021874
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary arterial hypertension and generalized scleroderma. A propos of 10 cases].
    Commeau P; Grollier G; Foucaúlt JP; Potier JC
    Poumon Coeur; 1983; 39(1):31-5. PubMed ID: 6866890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy.
    Allcock RJ; O'Sullivan JJ; Corris PA
    Arthritis Rheum; 2001 Jul; 44(7):1660-2. PubMed ID: 11465717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.
    Pauling JD; Gunawardena H; Coghlan JG; Easaw J; Suntharalingam J; McHugh NJ
    Rheumatology (Oxford); 2008 Sep; 47(9):1431-2. PubMed ID: 18603658
    [No Abstract]   [Full Text] [Related]  

  • 13. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma.
    Steen V
    Arthritis Rheum; 2005 Dec; 52(12):3698-700. PubMed ID: 16320319
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?
    Steen VD; Champion H
    Int J Clin Pract Suppl; 2011 Jan; (169):1-3. PubMed ID: 21176008
    [No Abstract]   [Full Text] [Related]  

  • 16. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension: screening and evaluation in scleroderma.
    York M; Farber HW
    Curr Opin Rheumatol; 2011 Nov; 23(6):536-44. PubMed ID: 21934501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
    Fischer A; Bull TM; Steen VD
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Gatzoulis MA; Settas L
    Semin Arthritis Rheum; 2010 Feb; 39(4):278-84. PubMed ID: 19539354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.